Tissue-engineered bone formation using human bone marrow stromal cells and novel beta-tricalcium phosphate

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Orthopedic Research

Background:

• Bone marrow stromal cells (hBMSCs) are crucial for bone regeneration.
• Beta-tricalcium phosphate (beta-TCP) is a promising biomaterial for bone defect repair.
• Developing effective scaffolds is key for successful bone tissue engineering.

Purpose of the Study:

• To evaluate the in vitro cellular proliferation and osteogenic differentiation of hBMSCs on novel porous beta-TCP scaffolds.
• To assess the in vivo bone formation capacity of these beta-TCP scaffolds when implanted ectopically in athymic mice.

Main Methods:

• Porous beta-TCP scaffolds (300-500 µm pores) were fabricated using the polymeric sponge method.
• hBMSCs were cultured on scaffolds in osteogenic or basal medium.
• Cell proliferation and differentiation were assessed via SEM, MTT assay, ALP activity, and OCN content.
• Scaffolds were implanted subcutaneously in athymic mice for in vivo bone formation evaluation.

Main Results:

• hBMSCs exhibited good attachment and rapid proliferation on beta-TCP scaffolds.
• Osteogenic medium significantly enhanced ALP activity and OCN content in vitro.
• In vivo, beta-TCP scaffolds with hBMSCs cultured in osteogenic medium showed woven bone formation at 4 weeks, progressing to remodeled lamellar bone by 12 weeks.
• No bone formation was observed in scaffolds without cells or osteogenic pre-culture.

Conclusions:

• Novel porous beta-TCP scaffolds effectively support hBMSC proliferation and osteogenic differentiation in vitro.
• These scaffolds demonstrate significant osteoconductive properties, promoting substantial bone formation in vivo.
• The findings highlight the potential of these beta-TCP scaffolds for applications in bone tissue engineering.